249 related articles for article (PubMed ID: 23206338)
41. Coreceptor competition for association with CD4 may change the susceptibility of human cells to infection with T-tropic and macrophagetropic isolates of human immunodeficiency virus type 1.
Lee S; Lapham CK; Chen H; King L; Manischewitz J; Romantseva T; Mostowski H; Stantchev TS; Broder CC; Golding H
J Virol; 2000 Jun; 74(11):5016-23. PubMed ID: 10799575
[TBL] [Abstract][Full Text] [Related]
42. Tumor necrosis factor alpha inhibits entry of human immunodeficiency virus type 1 into primary human macrophages: a selective role for the 75-kilodalton receptor.
Herbein G; Montaner LJ; Gordon S
J Virol; 1996 Nov; 70(11):7388-97. PubMed ID: 8892857
[TBL] [Abstract][Full Text] [Related]
43. The Inhibition of HIV-1 Entry Imposed by Interferon Inducible Transmembrane Proteins Is Independent of Co-Receptor Usage.
Yu J; Liu SL
Viruses; 2018 Aug; 10(8):. PubMed ID: 30087232
[TBL] [Abstract][Full Text] [Related]
44. Effect of RANTES on the infection of monocyte-derived primary macrophages by human immunodeficiency virus type 1 and type 2.
Ylisastigui L; Amzazi S; Bakri Y; Vizzavona J; Vita C; Gluckman JC; Benjouad A
Biomed Pharmacother; 1998; 52(10):447-53. PubMed ID: 9921414
[TBL] [Abstract][Full Text] [Related]
45. HIV-1 non-macrophage-tropic R5 envelope glycoproteins are not more tropic for entry into primary CD4+ T-cells than envelopes highly adapted for macrophages.
Musich T; O'Connell O; Gonzalez-Perez MP; Derdeyn CA; Peters PJ; Clapham PR
Retrovirology; 2015 Mar; 12():25. PubMed ID: 25809903
[TBL] [Abstract][Full Text] [Related]
46. In vitro activities of candidate microbicides against cell-associated HIV.
Selhorst P; Grupping K; Bourlet T; Delézay O; Ariën KK; Vanham G
Antimicrob Agents Chemother; 2012 Feb; 56(2):805-15. PubMed ID: 22083472
[TBL] [Abstract][Full Text] [Related]
47. Tat protein induces human immunodeficiency virus type 1 (HIV-1) coreceptors and promotes infection with both macrophage-tropic and T-lymphotropic HIV-1 strains.
Huang L; Bosch I; Hofmann W; Sodroski J; Pardee AB
J Virol; 1998 Nov; 72(11):8952-60. PubMed ID: 9765440
[TBL] [Abstract][Full Text] [Related]
48. Conferring specificity in redox pathways by enzymatic thiol/disulfide exchange reactions.
Netto LE; de Oliveira MA; Tairum CA; da Silva Neto JF
Free Radic Res; 2016; 50(2):206-45. PubMed ID: 26573728
[TBL] [Abstract][Full Text] [Related]
49. Enhanced replication of M-tropic HIV-1 strains in Herpesvirus saimiri immortalised T-cells which express CCR5.
Vella C; Zheng NN; Vella G; Atkins C; Bristow RG; Fickenscher H; Daniels RS
J Virol Methods; 1999 Apr; 79(1):51-63. PubMed ID: 10328535
[TBL] [Abstract][Full Text] [Related]
50. Human immunodeficiency virus type 1 uses lipid raft-colocalized CD4 and chemokine receptors for productive entry into CD4(+) T cells.
Popik W; Alce TM; Au WC
J Virol; 2002 May; 76(10):4709-22. PubMed ID: 11967288
[TBL] [Abstract][Full Text] [Related]
51. Identification of an unique CXCR4 epitope whose ligation inhibits infection by both CXCR4 and CCR5 tropic human immunodeficiency type-I viruses.
Adachi T; Tanaka R; Kodama A; Saito M; Takahashi Y; Ansari AA; Tanaka Y
Retrovirology; 2011 Oct; 8():84. PubMed ID: 22018245
[TBL] [Abstract][Full Text] [Related]
52. CD4-anchoring HIV-1 fusion inhibitor with enhanced potency and in vivo stability.
Ji C; Kopetzki E; Jekle A; Stubenrauch KG; Liu X; Zhang J; Rao E; Schlothauer T; Fischer S; Cammack N; Heilek G; Ries S; Sankuratri S
J Biol Chem; 2009 Feb; 284(8):5175-85. PubMed ID: 19097993
[TBL] [Abstract][Full Text] [Related]
53. Relationship between productive HIV-1 infection of macrophages and CCR5 utilization.
Hung CS; Pontow S; Ratner L
Virology; 1999 Nov; 264(2):278-88. PubMed ID: 10562492
[TBL] [Abstract][Full Text] [Related]
54. CXCR6-Mediated Simian Immunodeficiency Virus SIVagmSab Entry into Sabaeus African Green Monkey Lymphocytes Implicates Widespread Use of Non-CCR5 Pathways in Natural Host Infections.
Wetzel KS; Yi Y; Elliott STC; Romero D; Jacquelin B; Hahn BH; Muller-Trutwin M; Apetrei C; Pandrea I; Collman RG
J Virol; 2017 Feb; 91(4):. PubMed ID: 27903799
[TBL] [Abstract][Full Text] [Related]
55. Chemokine receptor-usage of clinical HIV-1 isolates obtained from patients with HIV-1 infection in late clinical stages using PHA-blast.
Matsuda S; Miyata M
Microbiol Immunol; 1999; 43(10):967-74. PubMed ID: 10585143
[TBL] [Abstract][Full Text] [Related]
56. [Deep lung--cellular reaction to HIV].
Tavares Marques MA; Alves V; Duque V; Botelho MF
Rev Port Pneumol; 2007; 13(2):175-212. PubMed ID: 17492233
[TBL] [Abstract][Full Text] [Related]
57. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
[TBL] [Abstract][Full Text] [Related]
58. The level of CD4 expression limits infection of primary rhesus monkey macrophages by a T-tropic simian immunodeficiency virus and macrophagetropic human immunodeficiency viruses.
Bannert N; Schenten D; Craig S; Sodroski J
J Virol; 2000 Dec; 74(23):10984-93. PubMed ID: 11069993
[TBL] [Abstract][Full Text] [Related]
59. Macrophage-tropic simian/human immunodeficiency virus chimeras use CXCR4, not CCR5, for infections of rhesus macaque peripheral blood mononuclear cells and alveolar macrophages.
Igarashi T; Donau OK; Imamichi H; Dumaurier MJ; Sadjadpour R; Plishka RJ; Buckler-White A; Buckler C; Suffredini AF; Lane HC; Moore JP; Martin MA
J Virol; 2003 Dec; 77(24):13042-52. PubMed ID: 14645561
[TBL] [Abstract][Full Text] [Related]
60. Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor.
Weissman D; Rabin RL; Arthos J; Rubbert A; Dybul M; Swofford R; Venkatesan S; Farber JM; Fauci AS
Nature; 1997 Oct; 389(6654):981-5. PubMed ID: 9353123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
